AU2001241168A1 - Drugs for complications of diabetes and neuropathy and utilization thereof - Google Patents

Drugs for complications of diabetes and neuropathy and utilization thereof

Info

Publication number: AU2001241168A1
Authority: AU; Australia
Prior art keywords: neuropathy; complications; diabetes; drugs; utilization
Prior art date: 2000-03-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001241168A

Other versions

AU2001241168B2 (en

Inventor

Yoshiro Kitahara

Kyoko Miura

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ajinomoto Co Inc

Original Assignee

Ajinomoto Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-17

Filing date

2001-03-15

Publication date

2001-12-06

2001-03-15 Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc

2001-03-15 Priority claimed from PCT/JP2001/002094 external-priority patent/WO2001068136A1/en

2001-12-06 Publication of AU2001241168A1 publication Critical patent/AU2001241168A1/en

2005-06-16 Application granted granted Critical

2005-06-16 Publication of AU2001241168B2 publication Critical patent/AU2001241168B2/en

2021-03-15 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

206010012601 Diabetes mellitus Diseases 0.000 title 1
206010029331 Neuropathy peripheral Diseases 0.000 title 1
239000003814 drug Substances 0.000 title 1
229940079593 drugs Drugs 0.000 title 1
201000001119 neuropathy Diseases 0.000 title 1

AU2001241168A 2000-03-17 2001-03-15 Drugs for complications of diabetes and neuropathy and utilization thereof Ceased AU2001241168B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000-76542		2000-03-17
JP2000076542		2000-03-17
PCT/JP2001/002094 WO2001068136A1 (en)	2000-03-17	2001-03-15	Drugs for complications of diabetes and neuropathy and utilization thereof

Publications (2)

Publication Number	Publication Date
AU2001241168A1 true AU2001241168A1 (en)	2001-12-06
AU2001241168B2 AU2001241168B2 (en)	2005-06-16

Family

ID=18594265

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU4116801A Pending AU4116801A (en)	2000-03-17	2001-03-15	Drugs for complications of diabetes and neuropathy and utilization thereof
AU2001241168A Ceased AU2001241168B2 (en)	2000-03-17	2001-03-15	Drugs for complications of diabetes and neuropathy and utilization thereof

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU4116801A Pending AU4116801A (en)	2000-03-17	2001-03-15	Drugs for complications of diabetes and neuropathy and utilization thereof

Country Status (20)

Country	Link
US (1)	US20030073729A1 (en)
EP (1)	EP1283054A4 (en)
KR (2)	KR20070104953A (en)
CN (2)	CN1234414C (en)
AU (2)	AU4116801A (en)
BR (1)	BR0109336A (en)
CA (1)	CA2403442A1 (en)
CZ (1)	CZ20023121A3 (en)
HK (1)	HK1055674A1 (en)
HU (1)	HUP0300325A3 (en)
IL (1)	IL151690A0 (en)
MX (1)	MXPA02009130A (en)
NO (1)	NO20024429L (en)
NZ (1)	NZ521366A (en)
PL (1)	PL357719A1 (en)
RU (1)	RU2281764C2 (en)
SK (1)	SK14922002A3 (en)
TW (1)	TWI305726B (en)
WO (1)	WO2001068136A1 (en)
ZA (1)	ZA200207223B (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE373635T1 (en) *	2000-10-18	2007-10-15	Ajinomoto Kk	METHOD FOR PRODUCING ACYLPHENYLALANINES
DE60129728T2 (en) *	2000-10-18	2008-04-24	Ajinomoto Co., Inc.	PROCESS FOR THE PRODUCTION OF NATEGLINIDE CRYSTALS
JPWO2002040010A1 (en) *	2000-10-24	2004-06-03	味の素株式会社	Nateglinide-containing hydrophilic pharmaceutical preparation
EP1334964B1 (en) *	2000-10-24	2007-08-15	Ajinomoto Co., Inc.	Process for producing b-form nateglinide crystal
CA2426263C (en) *	2000-10-24	2010-05-25	Ajinomoto Co., Inc.	Nateglinide-containing preparation
EP1695716A2 (en) *	2000-12-26	2006-08-30	Sankyo Company, Limited	Medicinal compositions containing diuretics and insulin sensitizers
US20050096367A1 (en) *	2002-05-28	2005-05-05	Yoshiro Kitahara	Pharmaceutical composition for suppression of the expression of ATP citrate lyase and use thereof
KR100983990B1 (en) *	2002-05-28	2010-09-30	아지노모토 가부시키가이샤	Medicinal composition for inhibiting the expression of ATP-citrate lyase
CN1665499A (en) *	2002-06-28	2005-09-07	橘生药品工业株式会社	Drug composition for prevention or inhibition of advance of diabetic complication
AU2003244082A1 (en) *	2002-06-28	2004-01-19	Kissei Pharmaceutical Co., Ltd.	Drug composition for blood sugar control
WO2004078741A1 (en) *	2003-03-03	2004-09-16	San-Ei Gen F.F.I., Inc.	Adiponectin expression promoter
ES2403378T3 (en) *	2003-09-17	2013-05-17	Board Of Regents, The University Of Texas System	Image studies of targeted pancreatic beta cells based on a mechanism
WO2005049006A1 (en) *	2003-11-21	2005-06-02	Ajinomoto Co., Inc.	Remedy for diabetes
JP4880591B2 (en)	2004-06-04	2012-02-22	テバファーマシューティカルインダストリーズリミティド	Pharmaceutical composition comprising irbesartan
TW200626163A (en) *	2004-09-22	2006-08-01	Kureha Corp	Agent for treating or preventing diabetic neuropathy
EP1891971A4 (en) *	2005-01-31	2010-02-03	Ajinomoto Kk	Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent
CN1947794B (en) *	2005-10-16	2010-09-01	安徽省现代中药研究中心	Medicine composition containing sulfonylurea compounds and phenoxy acid type compounds
AU2006311601A1 (en) *	2005-11-07	2007-05-18	Elixir Pharmaceuticals, Inc.	Combinations of metformin and meglitinide
MX2010011878A (en) *	2008-04-29	2011-04-11	Pharnext	Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate.
US8765669B2 (en) *	2008-06-17	2014-07-01	Glytech, Inc.	Glycosylated GLP-1 peptide
NO2424356T3 (en)	2009-04-29	2018-01-20
EP3563842A1 (en)	2009-04-29	2019-11-06	Amarin Pharmaceuticals Ireland Limited	Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
ES2661217T3 (en)	2009-06-15	2018-03-28	Amarin Pharmaceuticals Ireland Limited	Compositions and methods to reduce triglycerides without increasing LDL-C levels in a subject in simultaneous statin therapy
WO2011038122A1 (en)	2009-09-23	2011-03-31	Amarin Corporation Plc	Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
IT1398168B1 (en) *	2010-02-16	2013-02-14	Chiesi Farma Spa	USE OF ACTIVE INGREDIENTS IN COMBINATION FOR THE TREATMENT OF COMPLICATIONS OF DIABETES.
US11712429B2 (en)	2010-11-29	2023-08-01	Amarin Pharmaceuticals Ireland Limited	Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
EP2646013A4 (en)	2010-11-29	2014-03-26	Amarin Pharma Inc	Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
US11291643B2 (en)	2011-11-07	2022-04-05	Amarin Pharmaceuticals Ireland Limited	Methods of treating hypertriglyceridemia
EP2809316A1 (en) *	2012-01-31	2014-12-10	Mahmut Bilgic	Synergisctic combination comprising a meglitinide derivative and lipoic acid
US8492426B1 (en) *	2012-07-12	2013-07-23	Anis Ahmad	Use of carvedilol for treatment of diabetes mellitus
WO2014074552A2 (en)	2012-11-06	2014-05-15	Amarin Pharmaceuticals Ireland Limited	Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US20140187633A1 (en)	2012-12-31	2014-07-03	Amarin Pharmaceuticals Ireland Limited	Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en)	2013-02-06	2016-09-27	Amarin Pharmaceuticals Ireland Limited	Methods of reducing apolipoprotein C-III
US20140271841A1 (en)	2013-03-15	2014-09-18	Amarin Pharmaceuticals Ireland Limited	Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US9585859B2 (en)	2013-10-10	2017-03-07	Amarin Pharmaceuticals Ireland Limited	Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
WO2015195662A1 (en)	2014-06-16	2015-12-23	Amarin Pharmaceuticals Ireland Limited	Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
EP3700518A4 (en)	2018-09-24	2020-12-16	Amarin Pharmaceuticals Ireland Limited	Methods of reducing the risk of cardiovascular events in a subject
US10357476B1 (en)	2018-10-30	2019-07-23	Anis Ahmad	Method for treating coronary artery disease
EP4326244A1 (en)	2021-04-21	2024-02-28	Amarin Pharmaceuticals Ireland Limited	Methods of reducing the risk of heart failure

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES444756A1 (en) *	1975-01-31	1977-08-16	Ciba Geigy	Unsaturated amino-alcohols and their derivatives process for their manufacture and pharmaceutical compositions comprising them
JPS5938960B2 (en) *	1979-10-12	1984-09-20	呉羽化学工業株式会社	Aminobenzoic acid ester derivatives and pharmaceuticals containing the derivatives
JPS6354321A (en) *	1985-03-27	1988-03-08	Ajinomoto Co Inc	Blood sugar lowering agent
JP2764262B2 (en) *	1987-08-28	1998-06-11	持田製薬株式会社	Hydantoin derivative and pharmaceutical composition containing the same as active ingredient
JP2634450B2 (en) *	1988-11-11	1997-07-23	株式会社サンギ	Diabetes medication
NO179246C (en) *	1991-11-20	1996-09-04	Sankyo Co	Aromatic amino-alcohol derivatives and intermediates for their preparation
NO305987B1 (en) *	1994-04-11	1999-08-30	Sankyo Co	Heterocyclic compounds with antidiabetic activity, their use and pharmaceutical preparations containing these
JPH08157462A (en) *	1994-12-08	1996-06-18	Terumo Corp	Dioxothiazolidine derivative and medicinal composition containing the same
IL117208A0 (en) *	1995-02-23	1996-06-18	Nissan Chemical Ind Ltd	Indole type thiazolidines
JPH08245602A (en) *	1995-03-08	1996-09-24	Terumo Corp	Dioxothiazolidine derivative and medicinal composition containing the same as active ingredient
JPH0995445A (en) *	1995-07-24	1997-04-08	Kanegafuchi Chem Ind Co Ltd	Medicine for treating cerebral neurocyte disorder
US6006753A (en) *	1996-08-30	1999-12-28	Eli Lilly And Company	Use of GLP-1 or analogs to abolish catabolic changes after surgery
ES2364145T3 (en) *	1996-11-15	2011-08-25	Ajinomoto Co., Inc.	COMPOSITION OF NATEGLINIDA IN TABLETS.
WO1998056378A1 (en) *	1997-06-13	1998-12-17	Novo Nordisk A/S	Novel niddm regimen
WO1999035242A1 (en) *	1998-01-12	1999-07-15	Betagene, Inc.	Media for neuroendocrine cells
US6100300A (en) *	1998-04-28	2000-08-08	Bristol-Myers Squibb Company	Metformin formulations and method for treating intermittent claudication employing same
AR028299A1 (en) *	1999-09-17	2003-05-07	Novartis Ag	A PHARMACEUTICAL COMPOSITION THAT INCLUDES NATEGLINIDA, A PROCESS FOR ITS PREPARATION AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETY.
US6559188B1 (en) *	1999-09-17	2003-05-06	Novartis Ag	Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
DE60007592T2 (en) *	1999-09-30	2004-09-16	Pfizer Products Inc., Groton	Bicyclic pyrrolylamides as glycogen phosphorylase inhibitors
EP1218015A2 (en) *	1999-10-08	2002-07-03	Novartis AG	Pharmaceutical composition of nateglinide and another antidiabetic agent
US6586438B2 (en) *	1999-11-03	2003-07-01	Bristol-Myers Squibb Co.	Antidiabetic formulation and method
CN1413107A (en) *	1999-12-23	2003-04-23	诺瓦提斯公司	Use of hypoglycemic agent for treating impaired clucose metabolism
JP4822039B2 (en) *	1999-12-28	2011-11-24	味の素株式会社	Diabetic drug formulation for oral administration
DE60129728T2 (en) *	2000-10-18	2008-04-24	Ajinomoto Co., Inc.	PROCESS FOR THE PRODUCTION OF NATEGLINIDE CRYSTALS
ATE373635T1 (en) *	2000-10-18	2007-10-15	Ajinomoto Kk	METHOD FOR PRODUCING ACYLPHENYLALANINES
EP1334964B1 (en) *	2000-10-24	2007-08-15	Ajinomoto Co., Inc.	Process for producing b-form nateglinide crystal
CA2426263C (en) *	2000-10-24	2010-05-25	Ajinomoto Co., Inc.	Nateglinide-containing preparation
JP2004513935A (en) *	2000-11-17	2004-05-13	ノボ　ノルディスク　アクティーゼルスカブ	Glucagon antagonist / inverse agonist
US6652838B2 (en) *	2001-04-05	2003-11-25	Robert E. Weinstein	Method for treating diabetes mellitus
US6830759B2 (en) *	2002-06-28	2004-12-14	Ajinomoto Co., Inc.	Antidiabetic preparation for oral administration
EP1891971A4 (en) *	2005-01-31	2010-02-03	Ajinomoto Kk	Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent

2001
- 2001-03-15 KR KR1020077023592A patent/KR20070104953A/en not_active Application Discontinuation
- 2001-03-15 AU AU4116801A patent/AU4116801A/en active Pending
- 2001-03-15 WO PCT/JP2001/002094 patent/WO2001068136A1/en not_active Application Discontinuation
- 2001-03-15 CZ CZ20023121A patent/CZ20023121A3/en unknown
- 2001-03-15 BR BR0109336-3A patent/BR0109336A/en not_active Application Discontinuation
- 2001-03-15 EP EP01912425A patent/EP1283054A4/en not_active Withdrawn
- 2001-03-15 HU HU0300325A patent/HUP0300325A3/en unknown
- 2001-03-15 KR KR1020027012193A patent/KR100873585B1/en not_active IP Right Cessation
- 2001-03-15 CN CNB01806731XA patent/CN1234414C/en not_active Expired - Fee Related
- 2001-03-15 CN CNA2005101200487A patent/CN1768735A/en active Pending
- 2001-03-15 IL IL15169001A patent/IL151690A0/en unknown
- 2001-03-15 PL PL01357719A patent/PL357719A1/en unknown
- 2001-03-15 SK SK1492-2002A patent/SK14922002A3/en not_active Application Discontinuation
- 2001-03-15 CA CA002403442A patent/CA2403442A1/en not_active Abandoned
- 2001-03-15 RU RU2002127804/15A patent/RU2281764C2/en active
- 2001-03-15 AU AU2001241168A patent/AU2001241168B2/en not_active Ceased
- 2001-03-15 NZ NZ521366A patent/NZ521366A/en unknown
- 2001-03-15 MX MXPA02009130A patent/MXPA02009130A/en unknown
- 2001-03-16 TW TW090106246A patent/TWI305726B/en active
2002
- 2002-09-09 ZA ZA200207223A patent/ZA200207223B/en unknown
- 2002-09-16 NO NO20024429A patent/NO20024429L/en not_active Application Discontinuation
- 2002-09-17 US US10/244,433 patent/US20030073729A1/en not_active Abandoned
2003
- 2003-10-30 HK HK03107823A patent/HK1055674A1/en not_active IP Right Cessation

Publication	Publication Date	Title
AU2001241168A1 (en)	2001-12-06	Drugs for complications of diabetes and neuropathy and utilization thereof
AU4116801A (en)	2001-09-24	Drugs for complications of diabetes and neuropathy and utilization thereof
AU2002324737A1 (en)	2003-03-10	Anti-cancer and wound healing compounds
AU2002213357A1 (en)	2002-05-06	Variant igg3 rituxan r and therapeutic use thereof
AU2002303840A1 (en)	2002-12-09	Metering and packaging of controlled release medication
AU2001270778A1 (en)	2002-01-21	Production, stabilisation and use of reduced forms of pharmaceutical compounds
AU2002257562A1 (en)	2003-04-17	Deuterated 3-Piperidinopropiophenone and medicaments containing said compounds
AU2002214006A1 (en)	2002-04-22	Drugs for diabetes
AU2001288061A1 (en)	2002-04-15	Drug resistance-associated gene and use thereof
AU2001267645A1 (en)	2002-03-14	Cyclic urea compounds and preparation thereof
AU2001227084A1 (en)	2001-08-07	N-arylhydrazide compounds and use thereof as drugs
AU2002230781A1 (en)	2002-07-08	Pharmaceutical uses and synthesis of benzobicyclooctanes
AU2001294221A1 (en)	2002-06-27	Preventives and remedies for complications of diabetes
AU1053501A (en)	2001-05-14	Polyazanaphthalene compound and medicinal use thereof
AU2001264863A1 (en)	2001-12-03	Preparation of fagopyritols and uses therefor
AU2002229113A1 (en)	2002-04-29	Glucose transport-related genes and uses thereof
AU2570001A (en)	2001-07-09	Pharmaceutical composition and method for its manufacture
AU2001282527A1 (en)	2002-03-13	Antiparkinsonism drugs
AU4940800A (en)	2001-09-24	Polyketides and their synthesis
AU2001241583A1 (en)	2001-08-27	A human pyridoxal-phosphate dependent enzyme family member and uses therefor
AUPR548601A0 (en)	2001-06-28	Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2001260083A1 (en)	2001-12-03	New pharmaceutical composition and the process for its preparation
AU2001248199A1 (en)	2001-10-30	Crystal structure for rmlc and uses thereof
AU2001261116A1 (en)	2001-11-12	Method and compositions for drug discovery
AU2001284287A1 (en)	2002-03-22	Pharmaceutical combination containing salmeterol and fluticasone